Suppr超能文献

[浙江省乙型肝炎母婴传播预防策略的经济学评价]

[Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].

作者信息

Zeng Y B, Luo M L, He H Q, Deng X, Xie S Y, Fang Y

机构信息

School of Public Health, Xiamen University, Xiamen 361102, China.

Expanded Program Immunization Department of Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Jul 6;53(7):706-712. doi: 10.3760/cma.j.issn.0253-9624.2019.07.010.

Abstract

To evaluate the cost-benefit and cost-effectiveness of current strategy for preventing mother-to-child transmission (PMTCT) of hepatitis B virus. A decision tree model with the Markov process was developed and simulated over the lifetime of a birth cohort in Zhejiang Province in 2016. The current PMTCT strategy was compared with universal vaccination and non-vaccination. Costs were assessed from social perspective. Benefits were the savings from reduced costs associated with disease and effectiveness were measured by quality-adjusted of life-years (QALY) gained. The net present value (NPV), cost-benefit ratio (BCR) and incremental cost-effectiveness ratio (ICER) were calculated. Univariate and Probabilistic Sensitivity Analyses (PSA) were performed to assess parameter uncertainties. The parameters of costs and utilities value of hepatitis B-related disease came from the results of the field survey, which were obtained by face-to-face questionnaire survey combined with inpatient medical records, including eight county and municipal hospitals in Jinhua, Jiaxing and Taizhou. A total of 626 outpatients and 523 inpatient patients were investigated. The annual total costs of infection was calculated by combining the costs of outpatient and inpatient. The PMTCT strategy showed a net-gain as 38 323.78 CNY per person, with BCR as 21.10, which was higher than 36 357.80 CNY per person and 13.58 respectively of universal vaccination. Compared with universal vaccination, the PMTCT strategy would save 2 787.07 CNY per additional QALY gained for every person, indicating that PMTCT would be cost-saving. The most important parameters that could affect BCR and ICER were the vaccine coverage rate and costs of hepatitis B related diseases respectively. The PSA showed the PMTCT strategy was preferable as it would gain more QALY and save costs. The PMTCT strategy appeared as highly cost-beneficial and highly cost-effective. High vaccination rate was a key factor of high economic value.

摘要

评估当前预防乙型肝炎病毒母婴传播(PMTCT)策略的成本效益和成本效果。构建了一个带有马尔可夫过程的决策树模型,并在2016年浙江省一个出生队列的生命周期内进行模拟。将当前的PMTCT策略与普遍接种疫苗和不接种疫苗进行比较。从社会角度评估成本。效益是与疾病相关成本降低所带来的节省,效果通过获得的质量调整生命年(QALY)来衡量。计算净现值(NPV)、成本效益比(BCR)和增量成本效果比(ICER)。进行单因素和概率敏感性分析(PSA)以评估参数的不确定性。乙型肝炎相关疾病的成本和效用值参数来自现场调查结果,该调查通过面对面问卷调查结合住院病历获得,涉及金华、嘉兴和台州的8家县市级医院。共调查了626名门诊患者和523名住院患者。通过结合门诊和住院成本计算感染的年度总成本。PMTCT策略显示每人净收益为38323.78元,BCR为21.10,分别高于普遍接种疫苗的每人36357.80元和13.58。与普遍接种疫苗相比,PMTCT策略每人每增加一个QALY可节省2787.07元,表明PMTCT具有成本节约效果。影响BCR和ICER的最重要参数分别是疫苗接种率和乙型肝炎相关疾病的成本。PSA显示PMTCT策略更可取,因为它将获得更多QALY并节省成本。PMTCT策略具有很高的成本效益和成本效果。高接种率是高经济价值的关键因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验